featured
Dorzolamide–Timolol as Adjuvant Therapy in Neovascular AMD Refractory to Anti-VEGF Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Retina (Philadelphia, Pa.)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Adjuvant Topical Dorzolamide-Timolol in Patients With Neovascular Age-Related Macular Degeneration Refractory To Anti-Vascular Endothelial Growth Factor Therapy
Retina (Philadelphia, Pa.) 2018 Aug 29;[EPub Ahead of Print], JH Lee, SC Lee, SH Byeon, HJ Koh, SS Kim, CS LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.